ROC
MDT icon

Running Oak Capital’s Medtronic MDT Stock Holding History

Running Oak Capital’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-132,956
Closed -$10.5M – 64
2024
Q2 		$10.5M Buy
132,956
+22,557
+20% +$1.85M 1.62% 54
2024
Q1 		$9.62M Buy
110,399
+15,262
+16% +$1.3M 1.54% 49
2023
Q4 		$7.84M Buy
95,137
+19,493
+26% +$1.49M 1.54% 51
2023
Q3 		$5.93M Buy
75,644
+826
+1% +$69.1K 1.52% 52
2023
Q2 		$6.59M Buy
74,818
+6,749
+10% +$581K 1.62% 47
2023
Q1 		$5.49M Buy
68,069
+2,659
+4% +$217K 1.56% 49
2022
Q4 		$5.08M Buy
65,410
+8,576
+15% +$695K 1.49% 51
2022
Q3 		$4.59M Buy
+56,834
New +$5.11M 1.59% 46
2021
Q2 		$354K Sell
2,855
-42,207
-94% -$5.3M 0.2% 42
2021
Q1 		$5.32M Buy
45,062
+1,304
+3% +$153K 1.62% 47
2020
Q4 		$5.13M Sell
43,758
-1,265
-3% -$139K 1.71% 33
2020
Q3 		$4.68M Buy
45,023
+3,335
+8% +$335K 1.71% 37
2020
Q2 		$3.82M Buy
+41,688
New +$4M 1.51% 55

Other funds holding MDT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Running Oak Capital's MDT Position: Q3 2024 in Review

Running Oak Capital sold out of Medtronic (MDT) in Q3 2024, closing a stake of 132,956 shares — an estimated $10.5M sold.

Running Oak Capital first reported a position in MDT in Q2 2020 and held it in 13 quarters. The position peaked at $10.5M in Q2 2024. 2,069 funds tracked by Wall St. Rank hold MDT as of Q3 2024.

  • Running Oak Capital reported no remaining Medtronic position as of Q3 2024 after selling out during the quarter.
  • Running Oak Capital sold 132,956 Medtronic shares in Q3 2024, an estimated $10.5M.
  • Running Oak Capital first reported a position in Medtronic in Q2 2020 and held it in 13 quarters.
  • Running Oak Capital's Medtronic position peaked at $10.5M in Q2 2024.
  • 2,069 funds tracked by Wall St. Rank held Medtronic as of Q3 2024.

Based on Running Oak Capital's 13F filing for Q3 2024, filed 17 Oct 2024.